RT Journal Article
SR Electronic
T1 Risk factors for rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.03.20121251
DO 10.1101/2020.06.03.20121251
A1 Mpairwe, Harriet
A1 Nkurunungi, Gyaviira
A1 Tumwesige, Pius
A1 Akurut, Hellen
A1 Namutebi, Milly
A1 Nambuya, Irene
A1 Nnaluwooza, Marble
A1 Apule, Barbara
A1 Onen, Caroline
A1 Katongole, Tonny
A1 Niwagaba, Emmanuel
A1 Mukasa, Mike
A1 Webb, Emily L
A1 Elliott, Alison M
A1 Pearce, Neil
YR 2020
UL http://medrxiv.org/content/early/2020/06/05/2020.06.03.20121251.abstract
AB Background The prevalence of allergy-related diseases (ARDs), including rhinitis, allergic conjunctivitis and eczema, is on the increase in Africa and globally. The causes of this increase are not well established.Objectives To investigate the risk factors for ARDs among schoolchildren in Uganda.Methods We conducted a secondary data analysis of a large asthma case-control study involving 1,700 schoolchildren, 5-17 years, in urban Uganda. ARDs were defined according to the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire. Skin prick testing (SPT) was conducted using standard procedures and allergen-specific IgE (asIgE) using ImmunoCAP®. We used inverse probability weighting to account for the differences in the sampling fractions in all our analyses.Results The lifetime prevalence of reported rhinitis, allergic conjunctivitis and eczema was 43.3%, 39.5%, and 13.5%, respectively. There was overlap of ARDs, with 66.3% of 1,193 schoolchildren who reported having ever an ARDs (including asthma) reporting two or more. The important risk factors for ‘rhinitis ever’ were city residence at birth [adjusted odds ratio (95% confidence interval) 1.97 (1.26-3.10) compared to rural]; father’s [2.08 (1.57-2.75)] and mother’s history of allergic disease [2.29 (1.81-2.91)]; frequent de-worming in the last 12 months [1.80 (1.32-2.45), ≥2 versus none]; current high frequency of ‘trucks passing on the street near home’ [1.90 (1.19-3.03), ‘almost all the time’ versus rarely] and positive SPT [1.56 (1.24-1.96)] but not asIgE [1.33 (0.81-2.18)]. The same pattern of risk factors was observed for allergic conjunctivitis and eczema.Conclusion We found extensive multi-morbidity of, and overlap in the risk factors for, rhinitis, conjunctivitis, and eczema - similar to asthma risk factors - among schoolchildren in urban Uganda. This suggests a similar underlying cause for all ARDs, associated with exposure to urban lifestyles and environment in Uganda. Thus, epidemiological research should investigate causes of all ARDs as one disease entity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was mainly funded by Wellcome (reference no. 102512 Training fellowship to HM; 095778 Senior fellowship to AE). Additional support was obtained from the European Research Council (reference no. 668954 to NP), African Partnership for Chronic Disease Research (to GN) and UK Medical Research Council (reference no. MR/K012126/1 to EW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Uganda Virus Research Institute Research and Ethics Committee (reference number GC/127/14/09/481), and by the Uganda National Council for Science and Technology (reference number HS 1707).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available in London School of Hygiene & Tropical Medicine Data Compass at http://datacompass.lshtm.ac.uk/1761/. Data access is restricted due to the presence of potential identifiers. http://datacompass.lshtm.ac.uk/1761/